Fact Check
Fact Check: Is 'Livfavir' Cheaper Than Glenmark's 'Fabiflu'?
Glenmark Pharmaceuticals on June 20 had announced the launch of its antiviral drug Favipiravir, under the brand name 'Fabiflu', to treat mild to moderate COVID-19 cases in India. As per reports, based on clinical evidence and after the evaluation of data and in consultation with the Subject Expert...